YAP1 and cancer: YAP1, together with TAZ, has been considered an oncogene as overexpression or activation of YAP1 correlated with poor prognosis with cancer of variable organs, including ovary, [5,6] lung, [7] esophagus, [8] colon, [9], and pancreas [10].